It is thought that initially, the Pipeline device → disruption of flow into the aneurysm. The metallic barrier of the stent redirects blood flow along the course of the parent artery. At the same time, there is ↓ flow into the aneurysm, which → thrombosis within the aneurysm sac.
Over time the device acts as scaffolding over which neointima and endothelium grow and the device becomes incorporated into the vessel wall. Ultimately, this endothelialization process creates a biological seal across the aneurysm.